Patient 8 was an AML-M5 and was used for morphologic comparison with no or hypogranular cytoplasm (Patient 2 and 3, respectively), for similar cell distribution comparison in CD45 and scatter plots (Patient 7), and for the expression pattern comparison of all analyzed CD markers (Patients 1−7). Here, PTPRC is linked to acute myeloid leukemia.